Risk of death from COVID-19 in overweight and obese patients
DOI:
https://doi.org/10.36958/sep.v7i2.269Keywords:
COVID-19, overweight, obese, risk of deathAbstract
OBJECTIVE: estimate the risk of death from COVID-19 in overweight or obese patients at the Parque de la Industria Temporal Hospital, Guatemala City. METHOD: the study is a retrospective cohort study. 45 records of patients without overweight or obesity and 45 with overweight or obesity, with a diagnosis of COVID-19, were consecutively selected between November 15 and December 14, 2020 through intentional non-probabilistic sampling due to availability. RESULTS: the characteristics of a cohort of 90 patients were observed, comparing those who died (n=60) with the total number of patients. The reported mortality was 66.66%, with 48.33% of the deceased being underweight or normal weight and 51.66% being overweight or obese. Through a logistic regression, it was found that as adjusted risk factors for mortality stratified by overweight and obesity, being male is a significant risk factor for mortality, with a relative risk of 4.47 (95% CI 1.16-17.27). Furthermore, levels greater than 300 ng/mL of ferritin showed a strong association with the risk of mortality, with a relative risk of 9.09 (95% CI 1.82-45.4). CONCLUSION: being male and having high levels of ferritin are significant risk factors for mortality in patients admitted for COVID-19 at the Parque de la Industria Hospital during November 2020.
Downloads
References
Caci, G., Albini, A., Malerba, M., Noonan, D. M., Pochetti, P., & Polosa, R. (2020). COVID-19 and obesity: dangerous liaisons. Journal of Clinical Medicine, 9(8), 2511. https://doi.org/10.3390/jcm9082511 DOI: https://doi.org/10.3390/jcm9082511
Camargo Mendoza, J. P., Rodríguez Ariza, D. E., & Hernández Sabogal, J. C. (2022). Caracterización y factores pronóstico de mortalidad en pacientes ingresados en UCI por COVID-19 en un hospital público de referencia en Bogotá, Colombia. Acta Colombiana de Cuidado Intensivo, 22, 19-27. https://doi.org/10.1016/j.acci.2022.01.001 DOI: https://doi.org/10.1016/j.acci.2022.01.001
Fernández Crespo, S., Pérez-Matute, P., Íñiguez Martínez, M., Fernández-Villa, T., Domínguez-Garrido, E., Oteo, J. A., Marcos-Delgado, A., Flores, C., Riancho, J. A., Rojas-Martínez, A., Lapunzina, P., & Carracedo, Á. (2022). Gravedad de COVID-19 atribuible a obesidad según IMC y CUN-BAE. Semergen, 48(8), 101840. https://doi.org/10.1016/j.semerg.2022.101840 DOI: https://doi.org/10.1016/j.semerg.2022.101840
Galicia García, C., Santana Hernández, G. P., & Vega Sánchez, Á. E. (2021). Asociación de ferritina con deterioro ventilatorio y mortalidad debido a COVID-19 en terapia intensiva. Medicina Crítica (Colegio Mexicano de Medicina Crítica), 35(3), 121-129. https://doi.org/10.35366/100000 DOI: https://doi.org/10.35366/100000
González-Quiroz, Y. L., Demera-Santos, M. J., Freire-Pincay, M. L., & Mecías-Zambrano, C. L. (2021). Sensibilidad y especificidad del dímero D y ferritina como indicador de gravedad en COVID-19. Dominio de las Ciencias, 7(5), 213-232.
https://dialnet.unirioja.es/descarga/articulo/8383868.pdf
Goossens, G. H., Dicker, D., Farpour-Lambert, N. J., Frühbeck, G., Mullerova, D., Woodward, E., & Holm, J.-C. (2020). Obesity and COVID-19: A perspective from the European Association for the Study of Obesity on immunological perturbations, therapeutic challenges, and opportunities in obesity. Obesity Facts, 13(4), 439-452. https://doi.org/10.1159/000510719 DOI: https://doi.org/10.1159/000510719
Halpern, B., Da Costa Louzada, M. L., Aschner, P., Gerchman, F., Brajkovich, I., Faria-Neto, J. R., Escaño Polanco, F., Montero, J., & Marín Juliá, S. M. (2020). Obesity and COVID-19 in Latin America: a tragedy of two pandemics—Official document of the Latin American Federation of Obesity Societies. Obesity Reviews, 22(3), e13165. https://doi.org/10.1111/obr.13165 DOI: https://doi.org/10.1111/obr.13165
Jayawardena, R., Jeyakumar, D. T., Misra, A., Hills, A. P., & Ranasinghe, P. (2020). Obesity: a potential risk factor for infection and mortality in the current COVID-19 epidemic. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(6), 2199-2203. https://doi.org/10.1016/j.dsx.2020.11.001 DOI: https://doi.org/10.1016/j.dsx.2020.11.001
Katsoulis, M., Pasea, L., Lai, A. G., Dobson, R. J. B., Denaxas, S., Hemingway, H., & Banerjee, A. (2021). Obesity during the COVID-19 pandemic: both cause of high risk and potential effect of lockdown? A population-based electronic health record study. Public Health, 191, 41-47. https://doi.org/10.1016/j.puhe.2020.12.003 DOI: https://doi.org/10.1016/j.puhe.2020.12.003
Prensa Libre. (13 de marzo de 2023). Coronavirus: con más de 20 mil muertes, Guatemala cumple tres años de pandemia con el 47 % de la población vacunada. Prensa Libre. https://www.prensalibre.com/guatemala/comunitario/coronavirus-con-mas-de-20-mil-muertes-guatemala-cumple-tres-anos-de-pandemia-con-el-47-de-la-poblacion-vacunada/
Secretaría de Seguridad Alimentaria y Nutricional de la Presidencia de la República. (4 de marzo de 2024). El sobrepeso y la obesidad, los retos emergentes que forman parte del combate a la malnutrición. SESAN Guatemala. https://portal.sesan.gob.gt/2024/03/04/el-sobrepeso-y-la-obesidad-los-retos-emergentes-que-forman-parte-del-combate-a-la-malnutricion/
The Lancet Gastroenterology & Hepatology. (2021). Obesity: another ongoing pandemic. The Lancet Gastroenterology & Hepatology, 6(6), 411. https://doi.org/10.1016/S2468-1253(21)00143-6 DOI: https://doi.org/10.1016/S2468-1253(21)00143-6
Published
How to Cite
License
Copyright (c) 2024 Luis Felipe Teo Ochaeta
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors who publish in this journal accept the following conditions:
- The authors retain the copyright and assign to the journal the right of the first publication, with the work registered with the Creative Commons 4.0 attribution license, which allows third parties to use what is published as long as they mention the authorship of the work already the first publication in this magazine.
- Authors may make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (eg, include it in an institutional repository or publish it in a book) provided that they clearly indicate that the work it was first published in this magazine.
- Authors are allowed and encouraged to share their work online (for example: in institutional repositories or personal web pages) before and during the manuscript submission process, as it can lead to productive exchanges, more and more quick citation of published work (see The Effect of Open Access).
